We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 17, 2020

Avelumab–Cetuximab–Radiotherapy vs Standards of Care in Locally Advanced HNSCC

European Journal of Cancer


Additional Info

European Journal of Cancer
Avelumab–Cetuximab–Radiotherapy Versus Standards of Care in Locally Advanced Squamous-Cell Carcinoma of the Head and Neck: The Safety Phase of a Randomised Phase III Trial GORTEC 2017-01 (REACH)
Eur. J. Cancer 2020 Dec 01;141(xx)21-29, Y Tao, A Aupérin, X Sun, C Sire, L Martin, A Coutte, C Lafond, J Miroir, X Liem, F Rolland, C Even, F Nguyen, E Saada, A Maillard, N Colin-Batailhou, J Thariat, J Guigay, J Bourhis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading